RU98112707A - DRUG FOR TREATMENT OF SKIN CANCER AND PRE-CANCER SKIN DISEASES - Google Patents

DRUG FOR TREATMENT OF SKIN CANCER AND PRE-CANCER SKIN DISEASES

Info

Publication number
RU98112707A
RU98112707A RU98112707/14A RU98112707A RU98112707A RU 98112707 A RU98112707 A RU 98112707A RU 98112707/14 A RU98112707/14 A RU 98112707/14A RU 98112707 A RU98112707 A RU 98112707A RU 98112707 A RU98112707 A RU 98112707A
Authority
RU
Russia
Prior art keywords
cancer
skin
drug
treatment
skin diseases
Prior art date
Application number
RU98112707/14A
Other languages
Russian (ru)
Other versions
RU2146927C1 (en
Inventor
И.А. Студенцова
И.С. Мокринская
В.И. Романов
Р.С. Гараев
Р.Х. Хафизьянова
Л.Н. Залялютдинова
С.Н. Егорова
В.М. Шадрина
А.А. Муслинкин
Я.А. Левин
И.П. Гозман
Э.А. Гурылев
Original Assignee
Институт органической и физической химии им.А.Е.Арбузова Казанского научного центра РАН
Казанский государственный медицинский университет им.С.В.Курашова
Казанское химико-фармацевтическое производственное объединение (КХФПО) "Татхимфармпрепараты"
Filing date
Publication date
Application filed by Институт органической и физической химии им.А.Е.Арбузова Казанского научного центра РАН, Казанский государственный медицинский университет им.С.В.Курашова, Казанское химико-фармацевтическое производственное объединение (КХФПО) "Татхимфармпрепараты" filed Critical Институт органической и физической химии им.А.Е.Арбузова Казанского научного центра РАН
Priority to RU98112707A priority Critical patent/RU2146927C1/en
Priority claimed from RU98112707A external-priority patent/RU2146927C1/en
Publication of RU98112707A publication Critical patent/RU98112707A/en
Application granted granted Critical
Publication of RU2146927C1 publication Critical patent/RU2146927C1/en

Links

Claims (1)

1. Лекарственный препарат для лечения рака и предраковых заболеваний кожи, включающий действующее вещество с глицидильными группами и фармакологический разбавитель, отличающийся тем, что в качестве действующего вещества он содержит диглицидиловый эфир метилфосфоновой кислоты общей формулы
Figure 00000001

а в качестве разбавителя - ланолин, вазелин при следующем соотношении компонентов, мас.%:
Диглицидиловый эфир метилфосфоновой кислоты - 5-50
Ланолин безводный - 50-94
Вазелин - Не более 45
2. Лекарственное средство по п.1, отличающееся тем, что дополнительно содержит эмульсионные воски в количестве не более 10%.1. A drug for the treatment of cancer and precancerous skin diseases, including an active substance with glycidyl groups and a pharmacological diluent, characterized in that it contains methylphosphonic acid diglycidyl ether of the general formula
Figure 00000001

and as a diluent - lanolin, petrolatum in the following ratio of components, wt.%:
Methylphosphonic acid diglycidyl ether - 5-50
Anhydrous lanolin - 50-94
Vaseline - No more than 45
2. The drug according to claim 1, characterized in that it further comprises emulsion waxes in an amount of not more than 10%.
RU98112707A 1998-07-08 1998-07-08 Preparation for treatment of patient with cancer skin and precancer skin diseases RU2146927C1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98112707A RU2146927C1 (en) 1998-07-08 1998-07-08 Preparation for treatment of patient with cancer skin and precancer skin diseases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98112707A RU2146927C1 (en) 1998-07-08 1998-07-08 Preparation for treatment of patient with cancer skin and precancer skin diseases

Publications (2)

Publication Number Publication Date
RU98112707A true RU98112707A (en) 2000-03-10
RU2146927C1 RU2146927C1 (en) 2000-03-27

Family

ID=20207983

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98112707A RU2146927C1 (en) 1998-07-08 1998-07-08 Preparation for treatment of patient with cancer skin and precancer skin diseases

Country Status (1)

Country Link
RU (1) RU2146927C1 (en)

Similar Documents

Publication Publication Date Title
RU2220143C2 (en) Optically active derivatives of benzopyrane, pharmaceutical composition based on thereof and method for treatment of estrogen-sensitive diseases
RU97115713A (en) COMPOUNDS CONTAINING PETROPYRANES AND METHOD OF APPLICATION
BR0011856A (en) N-pyrazole a2a receptor agonists
RU95113862A (en) Pyrrolopyrimidine derivatives, pharmaceutical composition, intermediate compounds
EP1775305A3 (en) 6.Alpha.,9.alpha.-difluoro-17.alpha.-'(2-furanylcarboxyl) oxy]-11.beta.-hydroxy-16.alpha.-methyl-3-oxo-androst-1,4,-diene-17-carbothiotic acid s-fluoromethyl ester as an anti-inflammatory agent
EA200001224A1 (en) DERIVATIVES 2- (PURIN-9-IL) -TETRAHYDROFURAN-3,4-DIOLA
EA200201271A1 (en) INHIBITORS 11-BETA-HYDROXYSTEROID DEGYDROGENASE TYPE 1
BR0209777A (en) Stable liquid formulations
ATE67505T1 (en) TETRAPYRROL COMPOUNDS, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
EA199800943A1 (en) UREA DERIVATIVES AND THEIR USE AS INHIBITORS INOSINE-5`-MONO-PHOSPHATE-DEHYDROGENASE INHIBITORS
DE60134245D1 (en) (5- (2-HYDROXY-4-CHLOROBENZOYL) VALERIANIC ACID AND ITS SALTS, AND COMPOSITIONS FOR ADDING ACTIVITIES CONTAINING THESE COMPOUNDS
KR950031060A (en) Pharmaceutical composition for the treatment of osteoporosis
RU2000125889A (en) SUBSTITUTED BISINDOLYMALEIMIDES INTENDED TO INHIBIT CELL PROLIFERATION
RU96109699A (en) GUANIDIDES OF ALKENILKARBONIC ACIDS, METHOD OF THEIR RECEIVING, CONTAINING THEIR MEDICATION OR DIAGNOSTIC TOOL
RU2003134629A (en) CEPHEMA COMPOUNDS
ES472847A1 (en) 2-Bromo-ergosine and its acid addition salts, method for its preparation and its application as a medicine.
RU94039545A (en) New adenosine derivatives, methods of their synthesis, pharmaceutical compositions based on thereof, methods of preparing pharmaceutical compositions and their use
EA200101241A1 (en) INDOLA DERIVATIVES
RU98112707A (en) DRUG FOR TREATMENT OF SKIN CANCER AND PRE-CANCER SKIN DISEASES
RU95109157A (en) ANTIHIPPERGLICEMICALLY EFFECTIVE PHARMACEUTICAL COMPOSITION
KR910007881A (en) Aminopyridinylaminophenols and related compounds, methods for their preparation and their use as intermediates and pharmaceuticals
FR2420344A1 (en) NEW OXIME-ETHERS, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION.
FR2409987A1 (en) NEW SULFONANILIDE COMPOUNDS, THEIR PREPARATION PROCESS AND THEIR USE IN AGRICULTURE
ATE40987T1 (en) ACETYLENIC PHENOXYPROPANOL DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HIGH BLOOD PRESSURE.
DE69736985D1 (en) BIOLOGICAL ACTIVE COMPOSITION